FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk.
Ann Oncol
; 26(10): 2155-61, 2015 Oct.
Article
in En
| MEDLINE
| ID: mdl-26216382
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Lysis Syndrome
/
Allopurinol
/
Gout Suppressants
/
Hematologic Neoplasms
/
Febuxostat
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2015
Type:
Article
Affiliation country:
Italy